FDA Approves New Drug Treatment for High Blood Pressure Tekturna,
FDA Approves New Drug Treatment for High Blood Pressure
Tekturna, a new molecular entity (NME), is the first high blood pressure drug approved by FDA that inhibits renin, a kidney enzyme associated with the regulation of blood pressure.